In the first study of its type in the malaria field, Seattle BioMed has been awarded an $8.9 million grant from the Bill & Melinda Gates Foundation to identify biomarkers that will allow malaria vaccine design based on robust predictors of protective immunity. According to Ruobing Wang, M.D., Ph.D., the goal of the study is to identify and validate biomarkers that correlate with … [Read more...]